Optiver Holding
NUVB icon

Optiver Holding’s Nuvation Bio NUVB Stock Holding History

Optiver Holding’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.99K Buy
527
+183
+53% +$894 ﹤0.01% 2173
2026
Q1 		$1.48K Sell
344
-144
-30% -$802 ﹤0.01% 1967
2025
Q4 		$4.37K Sell
488
-1,878
-79% -$11.6K ﹤0.01% 1470
2025
Q3 		$8.75K Buy
+2,366
New +$6.45K ﹤0.01% 1377

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Optiver Holding's NUVB Position: Q2 2026 in Review

Optiver Holding increased its Nuvation Bio (NUVB) stake by 53% in Q2 2026, buying an estimated $894 and bringing the position to 527 shares worth $2.99K. The position accounts for ﹤0.01% of the portfolio, ranked #2173.

Optiver Holding first reported a position in NUVB in Q3 2025 and has held it in 4 quarters since. The position peaked at $8.75K in Q3 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Optiver Holding held 527 shares of Nuvation Bio worth $2.99K as of Q2 2026.
  • Optiver Holding bought 183 Nuvation Bio shares in Q2 2026, an estimated $894.
  • Nuvation Bio made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2173 holding.
  • Optiver Holding first reported a position in Nuvation Bio in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Nuvation Bio position peaked at $8.75K in Q3 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.